CRISPR Therapeutics
CRSP
#3072
Rank
NZ$7.00 B
Marketcap
$82.02
Share price
3.43%
Change (1 day)
-29.09%
Change (1 year)

CRISPR Therapeutics (CRSP) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$0.54 Billion

According to CRISPR Therapeutics's latest financial reports the company's total liabilities are NZ$0.54 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CRISPR Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.54 B-5.29%
2022-12-31NZ$0.57 B12.21%
2021-12-31NZ$0.51 B127.37%
2020-12-31NZ$0.22 B20.03%
2019-12-31NZ$0.18 B30.98%
2018-12-31NZ$0.14 B22.75%
2017-12-31NZ$0.11 B-27.35%
2016-12-31NZ$0.16 B-41.25%
2015-12-31NZ$0.27 B2439.08%
2014-12-31NZ$10.84 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$45.4 M-91.62%๐Ÿ‡บ๐Ÿ‡ธ USA